VIEMED HEALTHCARE, INC. Revenue
VIEMED HEALTHCARE, INC. (VMD) reported Revenue of $78.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-03
- VIEMED HEALTHCARE, INC. revenues for the quarter ending 2026-06-30 was $78.10M, a 23.85% increase year-over-year.
- VIEMED HEALTHCARE, INC. revenues for the quarter ending 2026-03-31 was $75.41M, a 27.54% increase year-over-year.
- VIEMED HEALTHCARE, INC. revenues for the quarter ending 2025-12-31 was $76.18M, a 25.51% increase year-over-year.
- VIEMED HEALTHCARE, INC. revenues for the quarter ending 2025-09-30 was $71.91M, a 23.98% increase year-over-year.
- VIEMED HEALTHCARE, INC. revenues for fiscal 2025 was $270.28M, a 20.52% increase from fiscal 2024.
- VIEMED HEALTHCARE, INC. revenues for fiscal 2024 was $224.26M, a 22.54% increase from fiscal 2023.
- VIEMED HEALTHCARE, INC. revenues for fiscal 2023 was $183.01M, a 31.82% increase from fiscal 2022.
- VIEMED HEALTHCARE, INC. revenues for fiscal 2022 was $138.83M, a 18.60% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $78.10M 10-Q · filed 2026-08-03 | $153.51M 10-Q · filed 2026-08-03 | $229.69M derived: sum of 3 quarters · filed 2026-08-03 | $301.61M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2026-03-31 | $75.41M 10-Q · filed 2026-05-05 | $151.59M derived: sum of 2 quarters · filed 2026-05-05 | $223.51M derived: sum of 3 quarters · filed 2026-05-05 | $286.56M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-12-31 | $76.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $148.09M derived: sum of 2 quarters · filed 2026-03-04 | $211.15M derived: sum of 3 quarters · filed 2026-08-03 | $270.28M 10-K · filed 2026-03-04 | |||
| 2025-09-30 | $71.91M 10-Q · filed 2025-11-05 | $134.97M derived: sum of 2 quarters · filed 2026-08-03 | $194.10M 10-Q · filed 2025-11-05 | $254.79M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-06-30 | $63.06M 10-Q · filed 2026-08-03 | $122.19M 10-Q · filed 2026-08-03 | $182.88M derived: sum of 3 quarters · filed 2026-08-03 | $240.88M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-03-31 | $59.13M 10-Q · filed 2026-05-05 | $119.82M derived: sum of 2 quarters · filed 2026-05-05 | $177.83M derived: sum of 3 quarters · filed 2026-05-05 | $232.79M derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | $60.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $118.70M derived: sum of 2 quarters · filed 2026-03-04 | $173.66M derived: sum of 3 quarters · filed 2026-03-04 | $224.26M 10-K · filed 2026-03-04 | |||
| 2024-09-30 | $58.00M 10-Q · filed 2025-11-05 | $112.97M derived: sum of 2 quarters · filed 2025-11-05 | $163.56M 10-Q · filed 2025-11-05 | $214.30M derived: sum of 4 quarters · filed 2026-03-04 | |||
| 2024-06-30 | $54.97M 10-Q · filed 2025-08-06 | $105.56M 10-Q · filed 2025-08-06 | $156.30M derived: sum of 3 quarters · filed 2026-03-04 | $205.70M derived: sum of 4 quarters · filed 2026-03-04 | |||
| 2024-03-31 | $50.59M 10-Q · filed 2025-05-07 | $101.33M derived: sum of 2 quarters · filed 2026-03-04 | $150.73M derived: sum of 3 quarters · filed 2026-03-04 | $194.04M derived: sum of 4 quarters · filed 2026-03-04 | |||
| 2023-12-31 | $50.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $100.14M derived: sum of 2 quarters · filed 2026-03-04 | $143.45M derived: sum of 3 quarters · filed 2026-03-04 | $183.01M 10-K · filed 2026-03-04 | |||
| 2023-09-30 | $49.40M 10-Q · filed 2024-11-06 | $92.71M derived: sum of 2 quarters · filed 2024-11-06 | $132.27M 10-Q · filed 2024-11-06 | $169.78M derived: sum of 4 quarters · filed 2025-03-10 | |||
| 2023-06-30 | $43.31M 10-Q · filed 2024-08-07 | $82.87M 10-Q · filed 2024-08-07 | $120.38M derived: sum of 3 quarters · filed 2025-03-10 | $156.13M derived: sum of 4 quarters · filed 2025-03-10 | |||
| 2023-03-31 | $39.56M 10-Q · filed 2024-05-06 | $77.06M derived: sum of 2 quarters · filed 2025-03-10 | $112.82M derived: sum of 3 quarters · filed 2025-03-10 | $146.13M derived: sum of 4 quarters · filed 2025-03-10 | |||
| 2022-12-31 | $37.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $73.27M derived: sum of 2 quarters · filed 2025-03-10 | $106.58M derived: sum of 3 quarters · filed 2025-03-10 | $138.83M 10-K · filed 2025-03-10 | |||
| 2022-09-30 | $35.76M 10-Q · filed 2023-11-01 | $69.07M derived: sum of 2 quarters · filed 2023-11-01 | $101.32M 10-Q · filed 2023-11-01 | $133.29M derived: sum of 4 quarters · filed 2023-11-01 | |||
| 2022-06-30 | $33.31M 10-Q · filed 2023-08-09 | $65.56M 10-Q · filed 2023-08-09 | $97.53M derived: sum of 3 quarters · filed 2023-08-09 | $126.81M derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | $32.26M 10-Q · filed 2023-05-08 | $64.22M derived: sum of 2 quarters · filed 2023-05-08 | $93.50M derived: sum of 3 quarters · filed 2023-05-08 | $120.90M derived: sum of 4 quarters · filed 2023-05-08 | |||
| 2021-12-31 | $31.96M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $61.25M derived: sum of 2 quarters · filed 2023-03-02 | $88.65M derived: sum of 3 quarters · filed 2023-03-02 | $117.06M 10-K · filed 2023-03-02 | |||
| 2021-09-30 | $29.29M 10-Q · filed 2022-11-01 | $56.68M derived: sum of 2 quarters · filed 2022-11-01 | $85.10M 10-Q · filed 2022-11-01 | $116.30M derived: sum of 4 quarters · filed 2022-11-01 | |||
| 2021-06-30 | $27.40M 10-Q · filed 2022-08-02 | $55.81M 10-Q · filed 2022-08-02 | $87.02M derived: sum of 3 quarters · filed 2022-08-02 | $120.46M derived: sum of 4 quarters · filed 2022-08-02 | |||
| 2021-03-31 | $28.42M 10-Q · filed 2022-05-03 | $59.62M derived: sum of 2 quarters · filed 2022-05-03 | $93.06M derived: sum of 3 quarters · filed 2022-05-03 | $135.92M derived: sum of 4 quarters · filed 2022-05-03 | |||
| 2020-12-31 | $31.20M 10-K · filed 2021-03-03 | $64.65M derived: sum of 2 quarters · filed 2021-11-02 | $107.50M derived: sum of 3 quarters · filed 2021-11-02 | $131.31M 10-K · filed 2022-03-07 | |||
| 2020-09-30 | $33.45M 10-Q · filed 2021-11-02 | $76.30M derived: sum of 2 quarters · filed 2021-11-02 | $100.11M 10-Q · filed 2021-11-02 | $121.56M derived: sum of 4 quarters · filed 2021-11-02 | |||
| 2020-06-30 | $42.85M 10-Q · filed 2021-08-03 | $66.66M 10-Q · filed 2021-08-03 | $88.11M derived: sum of 3 quarters · filed 2021-08-03 | $108.48M derived: sum of 4 quarters · filed 2021-08-03 | |||
| 2020-03-31 | $23.81M 10-Q · filed 2021-05-03 | $45.25M derived: sum of 2 quarters · filed 2021-05-03 | $65.62M derived: sum of 3 quarters · filed 2021-05-03 | $85.95M derived: sum of 4 quarters · filed 2021-05-03 | |||
| 2019-12-31 | $21.45M 10-K · filed 2021-03-03 | $41.82M derived: sum of 2 quarters · filed 2021-03-03 | $62.14M derived: sum of 3 quarters · filed 2021-03-03 | $80.26M 10-K · filed 2021-03-03 | |||
| 2019-09-30 | $20.37M 10-K · filed 2021-03-03 | $23.52M 10-Q · filed 2019-11-05 | $40.69M derived: sum of 2 quarters · filed 2021-03-03 | $58.81M 10-Q · filed 2020-11-04 | $66.52M 10-Q · filed 2019-11-05 | $77.17M derived: sum of 4 quarters · filed 2021-03-03 | |
| 2019-06-30 | $20.32M 10-K · filed 2021-03-03 | $22.55M 10-Q · filed 2019-08-09 | $38.44M 10-Q · filed 2020-08-04 | $42.99M 10-Q · filed 2019-08-09 | $56.80M derived: sum of 3 quarters · filed 2021-03-03 | $73.73M derived: sum of 4 quarters · filed 2021-03-03 | |
| 2019-03-31 | $18.11M 10-K · filed 2021-03-03 | $36.48M derived: sum of 2 quarters · filed 2021-03-03 | $53.41M derived: sum of 3 quarters · filed 2021-03-03 | $68.62M derived: sum of 4 quarters · filed 2021-03-03 | |||
| 2018-12-31 | $18.36M 10-K · filed 2020-03-04 | $35.29M derived: sum of 2 quarters · filed 2020-03-04 | $50.50M derived: sum of 3 quarters · filed 2020-03-04 | $64.46M 10-K · filed 2020-03-04 | |||
| 2018-09-30 | $16.93M 10-K · filed 2020-03-04 | $17.16M 10-Q · filed 2019-11-05 | $32.14M derived: sum of 2 quarters · filed 2020-03-04 | $46.78M 10-Q · filed 2019-11-05 | |||
| 2018-06-30 | $15.21M 10-K · filed 2020-03-04 | $15.51M 10-Q · filed 2019-08-09 | $29.62M 10-Q · filed 2019-08-09 | ||||
| 2018-03-31 | $13.96M 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |